Correlation Between HIM International and Sunmax Biotechnology
Can any of the company-specific risk be diversified away by investing in both HIM International and Sunmax Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HIM International and Sunmax Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HIM International Music and Sunmax Biotechnology Co, you can compare the effects of market volatilities on HIM International and Sunmax Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HIM International with a short position of Sunmax Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of HIM International and Sunmax Biotechnology.
Diversification Opportunities for HIM International and Sunmax Biotechnology
0.48 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between HIM and Sunmax is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding HIM International Music and Sunmax Biotechnology Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sunmax Biotechnology and HIM International is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HIM International Music are associated (or correlated) with Sunmax Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sunmax Biotechnology has no effect on the direction of HIM International i.e., HIM International and Sunmax Biotechnology go up and down completely randomly.
Pair Corralation between HIM International and Sunmax Biotechnology
Assuming the 90 days trading horizon HIM International Music is expected to under-perform the Sunmax Biotechnology. But the stock apears to be less risky and, when comparing its historical volatility, HIM International Music is 1.0 times less risky than Sunmax Biotechnology. The stock trades about -0.26 of its potential returns per unit of risk. The Sunmax Biotechnology Co is currently generating about -0.04 of returns per unit of risk over similar time horizon. If you would invest 28,500 in Sunmax Biotechnology Co on October 10, 2024 and sell it today you would lose (250.00) from holding Sunmax Biotechnology Co or give up 0.88% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
HIM International Music vs. Sunmax Biotechnology Co
Performance |
Timeline |
HIM International Music |
Sunmax Biotechnology |
HIM International and Sunmax Biotechnology Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with HIM International and Sunmax Biotechnology
The main advantage of trading using opposite HIM International and Sunmax Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HIM International position performs unexpectedly, Sunmax Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sunmax Biotechnology will offset losses from the drop in Sunmax Biotechnology's long position.HIM International vs. Camellia Metal Co | HIM International vs. Nova Technology | HIM International vs. STL Technology Co | HIM International vs. Golden Biotechnology |
Sunmax Biotechnology vs. EirGenix | Sunmax Biotechnology vs. Medigen Vaccine Biologics | Sunmax Biotechnology vs. OBI Pharma | Sunmax Biotechnology vs. TaiMed Biologics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |